Strategic Assessment for Portfolio Expansion of an Animal Health Pharma Company
A global animal health pharmaceutical client engaged Stellarix to gain end-to-end visibility into the nsMRA landscape relevant to feline chronic kidney disease (CKD). Our actionable intelligence enabled the firm to strengthen its competitive position by expanding its portfolio, streamlining partner shortlisting & prioritizing, and identifying market gaps. Client Background: A global animal health pharmaceutical company […]
Technology Feasibility Assessment for Viral Nervous Necrosis Prevention and Management
A leading biotechnology firm engaged Stellarix for competitive benchmarking and technology feasibility assessment. Our strategic insights helped the client accelerate market readiness by identifying gaps and pinpointing scalable innovations in aquaculture, specifically supporting the development of commercial vaccines for VNN (Viral Nervous Necrosis). Client Background: A Global life sciences and biotechnology conglomerate specializing in sustainable […]